Parkwood LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-13,977
Closed -$990K 100
2018
Q2
$990K Buy
13,977
+180
+1% +$12.7K 0.16% 66
2018
Q1
$1.04M Sell
13,797
-1,129
-8% -$89.7K 0.15% 67
2017
Q4
$1.07M Sell
14,926
-1,543
-9% -$117K 0.15% 84
2017
Q3
$1.33M Buy
16,469
+8,869
+117% +$678K 0.2% 72
2017
Q2
$538K Sell
7,600
-107,313
-93% -$7.14M 0.08% 173
2017
Q1
$7.8M Buy
114,913
+13,365
+13% +$940K 1.1% 18
2016
Q4
$7.27M Buy
101,548
+14,481
+17% +$1.08M 1.12% 13
2016
Q3
$6.89M Buy
87,067
+5,124
+6% +$416K 1.02% 10
2016
Q2
$6.84M Buy
+81,943
New +$7.27M 1.14% 11
2015
Q4
Sell
-2,077
Closed -$204K 449
2015
Q3
$204K Sell
2,077
-3,662
-64% -$407K 0.03% 416
2015
Q2
$672K Buy
5,739
+15
+0.3% +$1.64K 0.09% 138
2015
Q1
$562K Hold
5,724
0.07% 187
2014
Q4
$540K Buy
5,724
+1,644
+40% +$170K 0.07% 174
2014
Q3
$434K Sell
4,080
-3,442
-46% -$337K 0.09% 108
2014
Q2
$624K Sell
7,522
-1,019
-12% -$79.3K 0.14% 76
2014
Q1
$605K Buy
8,541
+179
+2% +$14K 0.15% 73
2013
Q4
$628K Buy
+8,362
New +$582K 0.16% 60

Other funds holding GILD

Parkwood LLC's GILD Position: Q3 2018 in Review

Parkwood LLC sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 13,977 shares — an estimated $990K sold.

Parkwood LLC first reported a position in GILD in Q4 2013 and held it in 17 quarters. The position peaked at $7.8M in Q1 2017. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Parkwood LLC reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Parkwood LLC sold 13,977 Gilead Sciences shares in Q3 2018, an estimated $990K.
  • Parkwood LLC first reported a position in Gilead Sciences in Q4 2013 and held it in 17 quarters.
  • Parkwood LLC's Gilead Sciences position peaked at $7.8M in Q1 2017.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Parkwood LLC's 13F filing for Q3 2018, filed 13 Nov 2018.